RBC Cautious on Phreesia Inc. (PHR): 'we will be listening for further color on any potential for improved visibility into pharma marketing spending'
Tweet Send to a Friend
RBC Capital analyst Sean Dodge reiterated an Outperform rating and $26.00 price target on Phreesia Inc. (NYSE: PHR).The analyst comments ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
